APA (7th ed.) Citation

Bhattacharya, D., Becker, C., Readhead, B., Goossens, N., Novik, J., Fiel, M. I., . . . Friedman, S. L. (2021). Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis. Scientific Reports, 11(1), 1. https://doi.org/10.1038/s41598-021-99008-2

Chicago Style (17th ed.) Citation

Bhattacharya, Dipankar, et al. "Repositioning of a Novel GABA-B Receptor Agonist, AZD3355 (Lesogaberan), for the Treatment of Non-alcoholic Steatohepatitis." Scientific Reports 11, no. 1 (2021): 1. https://doi.org/10.1038/s41598-021-99008-2.

MLA (9th ed.) Citation

Bhattacharya, Dipankar, et al. "Repositioning of a Novel GABA-B Receptor Agonist, AZD3355 (Lesogaberan), for the Treatment of Non-alcoholic Steatohepatitis." Scientific Reports, vol. 11, no. 1, 2021, p. 1, https://doi.org/10.1038/s41598-021-99008-2.